Page last updated: 2024-10-23

baclofen and Sjogren-Larsson Syndrome

baclofen has been researched along with Sjogren-Larsson Syndrome in 1 studies

Sjogren-Larsson Syndrome: An autosomal recessive neurocutaneous disorder characterized by severe ichthyosis MENTAL RETARDATION; SPASTIC PARAPLEGIA; and congenital ICHTHYOSIS. It is caused by mutation of gene encoding microsomal fatty ALDEHYDE DEHYDROGENASE leading to defect in fatty alcohol metabolism.

Research Excerpts

ExcerptRelevanceReference
"The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available."5.46Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017)
"The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available."1.46Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hidalgo, ET1
Orillac, C1
Hersh, A1
Harter, DH1
Rizzo, WB1
Weiner, HL1

Other Studies

1 other study available for baclofen and Sjogren-Larsson Syndrome

ArticleYear
Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.
    Journal of child neurology, 2017, Volume: 32, Issue:1

    Topics: Baclofen; Child, Preschool; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; M

2017